Mouwasat Medical Services Beheer
Beheer criteriumcontroles 1/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Nasser Sultan Al-Subaie
Algemeen directeur
n/a
Totale compensatie
| Percentage CEO-salaris | n/a |
| Dienstverband CEO | no data |
| Eigendom CEO | 17.5% |
| Management gemiddelde ambtstermijn | geen gegevens |
| Gemiddelde ambtstermijn bestuur | 4.8yrs |
Recente managementupdates
Recent updates
Do Mouwasat Medical Services' (TADAWUL:4002) Earnings Warrant Your Attention?
Sep 30
The Returns At Mouwasat Medical Services (TADAWUL:4002) Aren't Growing
Sep 12Mouwasat Medical Services Company's (TADAWUL:4002) Popularity With Investors Is Clear
Aug 06Does Mouwasat Medical Services (TADAWUL:4002) Deserve A Spot On Your Watchlist?
Jul 01Mouwasat Medical Services Company's (TADAWUL:4002) Popularity With Investors Is Clear
Apr 23Here's Why We Think Mouwasat Medical Services (TADAWUL:4002) Might Deserve Your Attention Today
Mar 18Slowing Rates Of Return At Mouwasat Medical Services (TADAWUL:4002) Leave Little Room For Excitement
Jan 23Here's Why Mouwasat Medical Services (TADAWUL:4002) Has Caught The Eye Of Investors
Dec 17Mouwasat Medical Services (TADAWUL:4002) Has Some Way To Go To Become A Multi-Bagger
Oct 05Should You Be Adding Mouwasat Medical Services (TADAWUL:4002) To Your Watchlist Today?
Sep 17The Returns At Mouwasat Medical Services (TADAWUL:4002) Aren't Growing
Jul 03Is Now The Time To Put Mouwasat Medical Services (TADAWUL:4002) On Your Watchlist?
Jun 12Returns At Mouwasat Medical Services (TADAWUL:4002) Appear To Be Weighed Down
Feb 24Mouwasat Medical Services Company's (TADAWUL:4002) Intrinsic Value Is Potentially 25% Below Its Share Price
Jan 18Return Trends At Mouwasat Medical Services (TADAWUL:4002) Aren't Appealing
Nov 24Returns At Mouwasat Medical Services (TADAWUL:4002) Appear To Be Weighed Down
Aug 24A Look At The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)
Jul 01Time To Worry? Analysts Just Downgraded Their Mouwasat Medical Services Company (TADAWUL:4002) Outlook
May 23Mouwasat Medical Services (TADAWUL:4002) Will Pay A Larger Dividend Than Last Year At ر.س2.75
Apr 29Mouwasat Medical Services (TADAWUL:4002) Is Increasing Its Dividend To ر.س2.75
Apr 15Investors Will Want Mouwasat Medical Services' (TADAWUL:4002) Growth In ROCE To Persist
Mar 17Calculating The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)
Mar 02If You Like EPS Growth Then Check Out Mouwasat Medical Services (TADAWUL:4002) Before It's Too Late
Feb 15The Return Trends At Mouwasat Medical Services (TADAWUL:4002) Look Promising
Dec 06Do Mouwasat Medical Services's (TADAWUL:4002) Earnings Warrant Your Attention?
Nov 16Mouwasat Medical Services (TADAWUL:4002) Is Achieving High Returns On Its Capital
Aug 29Does Mouwasat Medical Services (TADAWUL:4002) Deserve A Spot On Your Watchlist?
Aug 12Is Mouwasat Medical Services Company (TADAWUL:4002) Expensive For A Reason? A Look At Its Intrinsic Value
Jun 29Mouwasat Medical Services' (TADAWUL:4002) Returns On Capital Are Heading Higher
May 26Does Mouwasat Medical Services (TADAWUL:4002) Deserve A Spot On Your Watchlist?
May 11Is It Worth Buying Mouwasat Medical Services Company (TADAWUL:4002) For Its 1.4% Dividend Yield?
Apr 13Estimating The Intrinsic Value Of Mouwasat Medical Services Company (TADAWUL:4002)
Mar 16Is Mouwasat Medical Services Company's (TADAWUL:4002) Latest Stock Performance Being Led By Its Strong Fundamentals?
Mar 02Is Mouwasat Medical Services (TADAWUL:4002) A Future Multi-bagger?
Feb 13Here's Why I Think Mouwasat Medical Services (TADAWUL:4002) Is An Interesting Stock
Feb 01
What Kind Of Shareholders Hold The Majority In Mouwasat Medical Services Company's (TADAWUL:4002) Shares?
Jan 17What Makes Mouwasat Medical Services Company (TADAWUL:4002) A Great Dividend Stock?
Jan 04Mouwasat Medical Services (TADAWUL:4002) Has Gifted Shareholders With A Fantastic 137% Total Return On Their Investment
Dec 21Estimating The Fair Value Of Mouwasat Medical Services Company (TADAWUL:4002)
Dec 08Mouwasat Medical Services Company's (TADAWUL:4002) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?
Nov 24Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ر.س658m |
| Jun 30 2024 | n/a | n/a | ر.س665m |
| Mar 31 2024 | n/a | n/a | ر.س663m |
| Dec 31 2023 | n/a | n/a | ر.س658m |
| Sep 30 2023 | n/a | n/a | ر.س659m |
| Jun 30 2023 | n/a | n/a | ر.س625m |
| Mar 31 2023 | n/a | n/a | ر.س616m |
| Dec 31 2022 | ر.س458k | ر.س450k | ر.س599m |
Compensatie versus markt: Er zijn onvoldoende gegevens om vast te stellen of de totale vergoeding van Nasser Sultan redelijk is in vergelijking met bedrijven van vergelijkbare omvang in de SA markt.
Compensatie versus inkomsten: Er zijn onvoldoende gegevens om de beloning van Nasser Sultan te vergelijken met de prestaties van het bedrijf.
CEO
Nasser Sultan Al-Subaie (69 yo)
no data
Tenure
ر.س457,500
Compensatie
Mr. Nasser Sultan Al-hammad Al-subaie serves as the Chief Executive Officer and Vice Chairman of Al-Mouwasat Medical Services Company. Mr. Al-subaie holds a Certificate in managing health organizations fro...
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Vice-Chairman & CEO | no data | ر.س457.50k | 17.5% SAR 3.3b | |
| MD & Executive Director | no data | ر.س457.50k | 17.5% SAR 3.3b | |
| Deputy MD & Executive Director | no data | ر.س457.50k | 0.0048% SAR 898.7k | |
| Non-Executive Chairman | no data | ر.س459.00k | 17.5% SAR 3.3b | |
| Independent Director | no data | ر.س499.50k | geen gegevens | |
| Independent Director | 7.3yrs | ر.س508.50k | 0.025% SAR 4.8m | |
| Independent Director | 4.8yrs | ر.س474.00k | geen gegevens | |
| Director | 1.9yrs | geen gegevens | 0.00027% SAR 51.0k |
4.8yrs
Gemiddelde duur
63.5yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van 4002 wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.8 jaar).